Search research articles
Contact Us
Filters
Showing results (51-60 of 68) with videos related to
Page
of 7
Sort By:
Nature Communications
|
November 2, 2021
Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes
Brian D Lehmann, Antonio Colaprico, Tiago C Silva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 8, 2025
Phase Ib Trial of Fulvestrant, Palbociclib, and Erdafitinib, a pan-FGFR Tyrosine Kinase Inhibitor, in HR+/HER2- Metastatic Breast Cancer
Paula I Gonzalez-Ericsson, Nisha Unni, Komal Jhaveri, et al.
American Journal of Respiratory and Critical Care Medicine
|
November 6, 2023
Loss of p73 Expression Contributes to Chronic Obstructive Pulmonary Disease
Bradley W Richmond, Clayton B Marshall, Jessica B Blackburn, et al.
NPJ Breast Cancer
|
March 12, 2025
Population-specific patterns in assessing molecular subtypes of young black females with triple-negative breast cancer
Padma Sheila Rajagopal, Sonya Reid, Run Fan, et al.
Breast Cancer Research and Treatment
|
February 9, 2018
First international TNBC conference meeting report
Padmashree Rida, Angela Ogden, Ian O Ellis, et al.
JAMA Oncology
|
December 14, 2023
Atezolizumab in Combination With Carboplatin and Survival Outcomes in Patients With Metastatic Triple-Negative Breast Cancer: The TBCRC 043 Phase 2 Randomized Clinical Trial
Brian D Lehmann, Vandana G Abramson, E Claire Dees, et al.
Clinical and Translational Medicine
|
October 17, 2024
Single-cell transcriptional atlas of human breast cancers and model systems
Julia E Altman, Amy L Olex, Emily K Zboril, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 10, 2025
The Impact of JAK1 Pathogenic Variants and MHC-I Expression on Response to Immune Checkpoint Inhibition in Endometrial Cancer
Erica V Carballo, Paula Gonzalez-Ericsson, Brian D Lehmann, et al.
Molecular Oncology
|
August 7, 2013
SPARCL1 suppresses metastasis in prostate cancer
Yuzhu Xiang, Qingchao Qiu, Ming Jiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 12, 2019
TBCRC 032 IB/II Multicenter Study: Molecular Insights to AR Antagonist and PI3K Inhibitor Efficacy in Patients with AR<sup>+</sup> Metastatic Triple-Negative Breast Cancer
Brian D Lehmann, Vandana G Abramson, Melinda E Sanders, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 68) with videos related to
Sort By:
Page
of 7
Nature Communications
|
November 2, 2021
Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes
Brian D Lehmann, Antonio Colaprico, Tiago C Silva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 8, 2025
Phase Ib Trial of Fulvestrant, Palbociclib, and Erdafitinib, a pan-FGFR Tyrosine Kinase Inhibitor, in HR+/HER2- Metastatic Breast Cancer
Paula I Gonzalez-Ericsson, Nisha Unni, Komal Jhaveri, et al.
American Journal of Respiratory and Critical Care Medicine
|
November 6, 2023
Loss of p73 Expression Contributes to Chronic Obstructive Pulmonary Disease
Bradley W Richmond, Clayton B Marshall, Jessica B Blackburn, et al.
NPJ Breast Cancer
|
March 12, 2025
Population-specific patterns in assessing molecular subtypes of young black females with triple-negative breast cancer
Padma Sheila Rajagopal, Sonya Reid, Run Fan, et al.
Breast Cancer Research and Treatment
|
February 9, 2018
First international TNBC conference meeting report
Padmashree Rida, Angela Ogden, Ian O Ellis, et al.
JAMA Oncology
|
December 14, 2023
Atezolizumab in Combination With Carboplatin and Survival Outcomes in Patients With Metastatic Triple-Negative Breast Cancer: The TBCRC 043 Phase 2 Randomized Clinical Trial
Brian D Lehmann, Vandana G Abramson, E Claire Dees, et al.
Clinical and Translational Medicine
|
October 17, 2024
Single-cell transcriptional atlas of human breast cancers and model systems
Julia E Altman, Amy L Olex, Emily K Zboril, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 10, 2025
The Impact of JAK1 Pathogenic Variants and MHC-I Expression on Response to Immune Checkpoint Inhibition in Endometrial Cancer
Erica V Carballo, Paula Gonzalez-Ericsson, Brian D Lehmann, et al.
Molecular Oncology
|
August 7, 2013
SPARCL1 suppresses metastasis in prostate cancer
Yuzhu Xiang, Qingchao Qiu, Ming Jiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 12, 2019
TBCRC 032 IB/II Multicenter Study: Molecular Insights to AR Antagonist and PI3K Inhibitor Efficacy in Patients with AR<sup>+</sup> Metastatic Triple-Negative Breast Cancer
Brian D Lehmann, Vandana G Abramson, Melinda E Sanders, et al.
Page
of 7